Gland Pharma appoints Shyamakant Giri as CEO
Giri is currently the President (India Business & Emerging Markets) of Amneal Pharmaceuticals
Giri is currently the President (India Business & Emerging Markets) of Amneal Pharmaceuticals
To set a new standard in oncology, offering highly targeted radiation therapy that improves treatment precision, and accelerates recovery for cancer patients
CSPC will receive an upfront payment of $100 million from AstraZeneca
Sun Pharma will have the exclusive worldwide rights to commercialise Fibromun
He holds a Master’s in Management from the National University of Singapore
A first-in-class muscarinic agonist for the treatment of schizophrenia in adults
Dupixent is indicated for the approximately 300,000 adults in the US with inadequately controlled COPD and an eosinophilic phenotype
She reiterated the nation's commitment to eliminating TB as a public health problem by 2030 and ensuring a healthier future for all
NMC to continue its efforts to improve and enhance the quality of medical education in the country
Subscribe To Our Newsletter & Stay Updated